Position in BMY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$696,510
+$46,767 QoQ
Shares Held
12,088
+12.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,356
of 2,506 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prudent Man Advisors, LLC holds $9,454,706 across 4 Drug Manufacturers - General names. BMY ranks #3 (7.4% of the industry book) .
All Filings in BMY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $696,510 | 12,088 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $649,743 | 10,713 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $380,492 | 7,054 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $322,059 | 7,141 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $569,505 | 12,303 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $767,559 | 12,585 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $696,366 | 12,312 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $753,127 | 14,556 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $457,037 | 11,005 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $574,024 | 10,585 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $592,630 | 11,550 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $710,003 | 12,233 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $782,300 | 12,233 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $858,057 | 12,380 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $911,102 | 12,663 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $902,558 | 12,696 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $920,612 | 11,956 | Shares | Sole | 2022-08-05 | |
| No filing history on record for this holder in this stock. | ||||||